---
title: "Elevated One-Year Mortality After Nonfatal Opioid Overdose: Mechanisms and Context"
id: "pubmed-42758573"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42758573"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42758573/"
doi: "10.1080/00952990.2026.2714510"
published_at: "2026-09-18T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Elevated One-Year Mortality After Nonfatal Opioid Overdose: Mechanisms and Context
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42758573
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42758573/)
- **DOI:** [10.1080/00952990.2026.2714510](https://doi.org/10.1080%2F00952990.2026.2714510)
- **Published At:** 2026-09-18T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Survivors of nonfatal **opioid overdose** with prior overdose history have substantially higher **one-year all-cause mortality** than first-time survivors. - The authors conducted a focused literature review using PubMed-MEDLINE, supplemented by searches of JAMA Network, NEJM, and federal surveillance sources (CDC, SAMHSA), prioritizing publications from 2020–2026. - Elevated post-overdose mortality is attributed to at least six interacting mechanistic realms rather than solely reflecting substance-use severity. - Mechanistic realm 1: cumulative hypoxic-ischemic organ injury including hippocampal atrophy and leukoencephalopathy, which can produce lasting neurologic deficits. - Mechanistic realm 2: cardiopulmonary toxicity and opioid withdrawal–induced cardiomyopathy, contributing to increased cardiovascular risk after overdose. - Mechanistic realm 3: opioid-induced immunosuppression, increasing vulnerability to infections such as infective endocarditis and sepsis. - Mechanistic realm 4: neuropsychological sequelae including executive dysfunction, amnestic syndrome, and increased suicidality, which can impair recovery and increase mortality risk. - Mechanistic realm 5: pharmacologic factors including **opioid tolerance** and **fentanyl**‑specific pharmacotoxicology that heighten overdose risk and complicate reversal and treatment. - Mechanistic realm 6: sociostructural determinants — housing instability, racial disparities, and treatment gaps — that limit access to care and increase vulnerability; for example, some high-risk groups, including Medicare disability beneficiaries, had fewer than 5% receiving **medication for opioid use disorder (MOUD)** after nonfatal overdose. - The authors propose that elevated one-year mortality after nonfatal overdose is a multi-organ, multi-system consequence of repeated physiologic insult, neuropsychological injury, and socioeconomic factors, not merely a proxy for severity of substance use.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42758573/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42758573%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42758573/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42758573/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42758573/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/c24ab723-7c80-48cd-9c68-022ded852586/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42758573/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42758573/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42758573/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42758573%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42758573%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42758573/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42758573/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42758573/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42758573/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42758573/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42758573/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42758573/#abstract) Title & authors Abstract Am J Drug Alcohol Abuse Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Am+J+Drug+Alcohol+Abuse%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Am+J+Drug+Alcohol+Abuse%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42758573/) . 2026 Sep 18:1-7. doi: 10.1080/00952990.2026.2714510. Online ahead of print. # Dying in the year after surviving: a perspective on elevated all-cause mortality among opioid overdose survivors [Robert B Raffa](https://pubmed.ncbi.nlm.nih.gov/?term=Raffa+RB&cauthor_id=42758573)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#full-view-affiliation-1 "School of Pharmacy, Temple University \(Emeritus\), Philadelphia, PA, USA.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#full-view-affiliation-2 "Research and Development, Enalare Therapeutics, Mullica Hill, NJ, USA."), [Albert Dahan](https://pubmed.ncbi.nlm.nih.gov/?term=Dahan+A&cauthor_id=42758573)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#full-view-affiliation-2 "Research and Development, Enalare Therapeutics, Mullica Hill, NJ, USA.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#full-view-affiliation-3 "Clinical Sciences, MediD Consultancy Group, Amsterdam, The Netherlands."), [Joseph V Pergolizzi](https://pubmed.ncbi.nlm.nih.gov/?term=Pergolizzi+JV&cauthor_id=42758573)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#full-view-affiliation-2 "Research and Development, Enalare Therapeutics, Mullica Hill, NJ, USA.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#full-view-affiliation-4 "Anesthesiology, NEMA Research, Naples, FL, USA."), [Eugene Vortsman](https://pubmed.ncbi.nlm.nih.gov/?term=Vortsman+E&cauthor_id=42758573)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#full-view-affiliation-5 "Emergency Department, Long Island Jewish Medical Center at Northwell Health, New York, NY, USA."), [Lynn Webster](https://pubmed.ncbi.nlm.nih.gov/?term=Webster+L&cauthor_id=42758573)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#full-view-affiliation-6 "Department of Health Equity Policy, Center for U.S. Policy, Washington, DC, USA.") Affiliations Expand ### Affiliations * 1 School of Pharmacy, Temple University (Emeritus), Philadelphia, PA, USA. * 2 Research and Development, Enalare Therapeutics, Mullica Hill, NJ, USA. * 3 Clinical Sciences, MediD Consultancy Group, Amsterdam, The Netherlands. * 4 Anesthesiology, NEMA Research, Naples, FL, USA. * 5 Emergency Department, Long Island Jewish Medical Center at Northwell Health, New York, NY, USA. * 6 Department of Health Equity Policy, Center for U.S. Policy, Washington, DC, USA. * PMID: **42758573** * DOI: [ 10.1080/00952990.2026.2714510 ](https://doi.org/10.1080/00952990.2026.2714510) Item in Clipboard # Dying in the year after surviving: a perspective on elevated all-cause mortality among opioid overdose survivors Robert B Raffa et al. Am J Drug Alcohol Abuse. 2026. Show details Display options Display options Format Abstract PubMed PMID Am J Drug Alcohol Abuse Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Am+J+Drug+Alcohol+Abuse%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Am+J+Drug+Alcohol+Abuse%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42758573/) . 2026 Sep 18:1-7. doi: 10.1080/00952990.2026.2714510. Online ahead of print. ### Authors [Robert B Raffa](https://pubmed.ncbi.nlm.nih.gov/?term=Raffa+RB&cauthor_id=42758573)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#short-view-affiliation-1 "School of Pharmacy, Temple University \(Emeritus\), Philadelphia, PA, USA.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#short-view-affiliation-2 "Research and Development, Enalare Therapeutics, Mullica Hill, NJ, USA."), [Albert Dahan](https://pubmed.ncbi.nlm.nih.gov/?term=Dahan+A&cauthor_id=42758573)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#short-view-affiliation-2 "Research and Development, Enalare Therapeutics, Mullica Hill, NJ, USA.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#short-view-affiliation-3 "Clinical Sciences, MediD Consultancy Group, Amsterdam, The Netherlands."), [Joseph V Pergolizzi](https://pubmed.ncbi.nlm.nih.gov/?term=Pergolizzi+JV&cauthor_id=42758573)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#short-view-affiliation-2 "Research and Development, Enalare Therapeutics, Mullica Hill, NJ, USA.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#short-view-affiliation-4 "Anesthesiology, NEMA Research, Naples, FL, USA."), [Eugene Vortsman](https://pubmed.ncbi.nlm.nih.gov/?term=Vortsman+E&cauthor_id=42758573)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#short-view-affiliation-5 "Emergency Department, Long Island Jewish Medical Center at Northwell Health, New York, NY, USA."), [Lynn Webster](https://pubmed.ncbi.nlm.nih.gov/?term=Webster+L&cauthor_id=42758573)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42758573/#short-view-affiliation-6 "Department of Health Equity Policy, Center for U.S. Policy, Washington, DC, USA.") ### Affiliations * 1 School of Pharmacy, Temple University (Emeritus), Philadelphia, PA, USA. * 2 Research and Development, Enalare Therapeutics, Mullica Hill, NJ, USA. * 3 Clinical Sciences, MediD Consultancy Group, Amsterdam, The Netherlands. * 4 Anesthesiology, NEMA Research, Naples, FL, USA. * 5 Emergency Department, Long Island Jewish Medical Center at Northwell Health, New York, NY, USA. * 6 Department of Health Equity Policy, Center for U.S. Policy, Washington, DC, USA. * PMID: **42758573** * DOI: [ 10.1080/00952990.2026.2714510 ](https://doi.org/10.1080/00952990.2026.2714510) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID ## Abstract It has been reported that opioid overdose survivors who had a prior non-fatal opioid overdose have a substantially elevated one-year all-cause mortality compared to first-time overdose survivors. The objective of this Perspective was to construct a framework for assessing the observed elevated post-overdose one-year mortality burden. We reviewed published peer-reviewed literature in the English language identified through PubMed-MEDLINE, with supplemental searches of JAMA Network, the New England Journal of Medicine (NEJM), and federal surveillance data (e.g. CDC and SAMHSA). References were selected for relevance, prioritizing 2020-2026, and were used as direction to additional sources of material. It was found that elevated one-year mortality among prior overdose survivors reflects at least six interacting mechanistic realms: (1) cumulative hypoxic-ischemic organ injury, including hippocampal atrophy and leukoencephalopathy; (2) cardiopulmonary toxicity and opioid withdrawal-induced cardiomyopathy; (3) opioid-induced immunosuppression with heightened vulnerability to infective endocarditis and sepsis; (4) neuropsychological sequelae including executive dysfunction, amnestic syndrome, and suicidality; (5) opioid tolerance compounded by fentanyl-specific pharmacotoxicology; and (6) sociostructural determinants such as housing instability, racial disparities, and treatment gap with some high-risk populations, including Medicare disability beneficiaries, showing that fewer than 5% received medication for opioid use disorder (MOUD) after nonfatal overdose. Therefore, we propose that elevated postoverdose one-year mortality is not simply a marker of substance-use severity, but also a multi-organ, multi-system consequence of repeated physiological insult, neuropsychological injury, and socioeconomic circumstance. **Keywords:** Non-fatal opioid overdose; immunosuppression; neuropsychological sequelae; one-year postoverdose mortality; racism; socioeconomic factors; toxicity. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/42758573/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42758573%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/42758573/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42758573%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42758573%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/42758573/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Follow NCBI [ Twitter ](https://twitter.com/ncbi) [ Facebook ](https://www.facebook.com/ncbi.nlm) [ LinkedIn ](https://www.linkedin.com/company/ncbinlm) [ GitHub ](https://github.com/ncbi) [ ](https://ncbiinsights.ncbi.nlm.nih.gov/) [Connect with NLM](https://www.nlm.nih.gov/socialmedia/index.html) * [ Twitter ](https://twitter.com/NLM_NIH) * [ SM-Facebook ](https://www.facebook.com/nationallibraryofmedicine) * [ SM-Youtube ](https://www.youtube.com/user/NLMNIH) National Library of Medicine [8600 Rockville Pike Bethesda, MD 20894](https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323) [Web Policies](https://www.nlm.nih.gov/web_policies.html) [FOIA](https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office) [HHS Vulnerability Disclosure](https://www.hhs.gov/vulnerability-disclosure-policy/index.html) [Help](https://support.nlm.nih.gov/?pagename=pubmed%3Apubmed%3Aabstract%3ANONE) [Accessibility](https://www.nlm.nih.gov/accessibility.html) [Careers](https://www.nlm.nih.gov/careers/careers.html) * [NLM](https://www.nlm.nih.gov/) * [NIH](https://www.nih.gov/) * [HHS](https://www.hhs.gov/) * [USA.gov](https://www.usa.gov/)
## Related Clinical Research

- [Epidermolysis Bullosa in Pediatric Emergency Departments: Clinical Characteristics and Management](https://medichelpline.com/clinical-feed/pubmed-42755255.md) (DOI: 10.1097/PEC.0000000000003703)
- [Postpartum infections in Norway 2012–2020: incidence trends and key risk factors](https://medichelpline.com/clinical-feed/pubmed-42757709.md) (DOI: 10.1111/aogs.70355)
- [Persistent critical illness in mechanically ventilated acute hypoxic respiratory failure: prevalen](https://medichelpline.com/clinical-feed/plos-one-9-persistent-critical-illness-in-acute-hypoxic-respiratory-failure-a.md)
- [Entropy-Based Framework to Quantify Dynamic Epistemic Uncertainty in Clinical LLM Reasoning](https://medichelpline.com/clinical-feed/medrxiv-1-novel-entropy-based-framework-for-quantifying-dynamic-epistemic-uncertainty-in.md)
- [Why AI for Older Adults Requires Careful Scrutiny, a Geriatrician Warns](https://medichelpline.com/clinical-feed/stat-news-3-stat-a-geriatrician-explains-why-ai-for-older-adults-deserves-careful-scrutiny.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.